CoChat

Tumour necrosis factor‐alpha plasma levels in elderly patients with Type 2 diabetes mellitus—observations over 2 years

Lechleitner, M., Herold, M., Dzien‐Bischinger, C., Hoppichler, F., Dzien, A. · 2002 · Diabetic Medicine
Cited by 59

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Aims The cytokine tumour necrosis factor‐alpha (TNF‐α) is involved in the development of obesity‐linked insulin resistance. TNF‐α plasma levels rise with increasing age and might thus also be related to metabolic control in Type 2 diabetes mellitus. We have studied the relationship of TNF‐α plasma levels to glycaemic control in elderly patients with Type 2 diabetes over 2 years. Methods Clinical and laboratory data of 53 patients (26 women, 27 men) with Type 2 diabetes (mean age 71.6 ± 5.6 years) were regularly evaluated over 2 years, and the relationship to anti‐diabetic treatment regimens analysed. TNF‐α plasma level was measured by a solid‐phase enzyme amplified sensitivity immunoassay. Results TNF‐α plasma levels increased significantly from 16.2 ± 9.6 pg/ml at baseline to 28.0 ± 13.8 pg/ml after 2 years (P = 0.028). HbA 1c values also increased from 6.4 ± 1.2% to 7.7 ± 1.6% (P = 0.046). Mean body mass index of the patients remained almost constant, while a moderate increase in the percentage of body fat (34.5 ± 7.0% to 35.3 ± 6.9%; P= 0.061) and in waist–hip ratio was observed (0.86 ± 0.04 to 0.88 ± 0.04; P= 0.052). After adjustment for covariates multivariate analysis demonstrated that TNF‐α plasma levels are positively related to the HbA 1c values of the whole study population at the baseline control and after 2 years. TNF‐α also revealed a positive correlation to the percentage of body fat. Conclusions In elderly patients with Type 2 diabetes TNF‐α plasma levels revealed a continuous increase during an observation period of 2 years. This increase in TNF‐α plasma levels might add another aspect to the worsening of glycaemic control in the progression of Type 2 diabetes. Diabet. Med. 19, 949–953 (2002)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.2002.00846.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 59

Metadata

Authors
Lechleitner, M., Herold, M., Dzien‐Bischinger, C., Hoppichler, F., & Dzien, A.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2002-11
Volume
19
Issue
11
Pages
949-953
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1969471622
Cited by
59
References
5
FWCI
1.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumour necrosis factor‐alpha plasma levels in elderly patients with Type 2 diabetes mellitus—observations over 2 years. https://app.cochat.ai/papers/10.1046/j.1464-5491.2002.00846.x
The paper
Lechleitner, M., Herold, M., Dzien‐Bischinger, C., Hoppichler, F., & Dzien, A. (2002). Tumour necrosis factor‐alpha plasma levels in elderly patients with Type 2 diabetes mellitus—observations over 2 years. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2002.00846.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.